← FDA Drug Approvals (Drugs@FDA)

NPLATE

BLA · Biologics License Application · Sponsor: AMGEN · Approved 2008-08-22

Drug application

FDA Application #

BLA125268

Application type

Biologics License Application

Brand name

NPLATE

Generic name

ROMIPLOSTIM

Active ingredients

ROMIPLOSTIM

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

AMGEN

Manufacturer

Amgen, Inc

First approval

2008-08-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown